細胞凍結保存市場：製品タイプ別、用途別、エンドユーザー別、地域別

世界の細胞凍結保存市場は、2025年には124億4,000万米ドルと推定され、2032年には536億4,000万米ドルに達すると予測され、2025～2032年のCAGRは23.2%で成長する見込みです。

図.細胞凍結保存市場シェア（%）、2025年地域別

細胞凍結保存は、液体窒素を用いて細胞を極低温、通常は-80℃以下に冷却することで細胞を保存します。細胞の生存率に影響を与えることなく、非常に長期間細胞を保存することができます。がんや遺伝性疾患の増加、再生医療研究、幹細胞バンキング、不妊治療、組織工学への投資の増加といった要因が、研究機関や病院全体での細胞凍結保存プロセスの需要を押し上げる可能性があります。凍結保存装置やソリューションの技術的進歩も市場成長を後押しします。しかし、凍結保存の手順や機器に関連する高コストは、予測期間中の市場成長を妨げる可能性があります。

市場力学

世界の細胞凍結保存市場成長の主要原動力は、慢性疾患や生命を脅かす疾患の罹患率の上昇です。がんや遺伝性疾患の世界の蔓延は、凍結保存細胞に大きく依存する研究活動、細胞療法、臨床検査の需要を押し上げています。世界がん研究基金によると、2020年には世界で約1,800万件の新たながん症例が報告されます。さらに、再生医療、幹細胞研究、医療バイオテクノロジーの革新に対する官民双方の投資の増加も、凍結保存プロセスの取り込みを後押ししています。しかし、凍結保存装置、液体窒素、全体的な手順に関連する高コストが市場成長の妨げとなる可能性があります。また、熟練した専門家の不足や、凍結プロセスに時間がかかる間の技術的課題も市場成長の妨げとなる可能性があります。ロボット凍結保存技術や機器の開発が進んでいるため、有利な市場成長機会がもたらされる可能性があります。

この調査の主要特徴

• 本レポートは、世界の細胞凍結保存市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模と複合年間成長率（CAGR%）を提供しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の細胞凍結保存市場の主要企業をプロファイルしています。
• このレポートから洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の細胞凍結保存市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
• 利害関係者は、世界の細胞凍結保存市場分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の細胞凍結保存市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の細胞凍結保存市場、製品タイプ別、2020～2032年（10億米ドル）

• イントロダクション
• 凍結防止剤
• グリセロール
• ジメチルスルホキシド（DMSO）
• その他
• 装置
• インキュベーター
• 液体窒素供給タンク
• 冷凍庫
• その他

第6章 世界の細胞凍結保存市場、用途別、2020～2032年（10億米ドル）

• イントロダクション
• 幹細胞
• 卵母細胞と胚細胞
• 精子細胞
• 肝細胞
• その他

第7章 世界の細胞凍結保存市場、エンドユーザー別、2020～2032年（10億米ドル）

• イントロダクション
• バイオ医薬品と製薬会社
• 研究機関
• バイオバンク
• 体外受精クリニック
• その他

第8章 世界の細胞凍結保存市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza Group Ltd.
  • STEMCELL Technologies Inc.
  • BioLife Solutions, Inc.
  • Cryolife, Inc.
  • Organ Recovery Systems Inc.
  • Custom Biogenic Systems
  • Sartorius AG
  • Takara Bio Inc.
  • Chart Industries, Inc.
  • Biocision, LLC
  • Cardinal Health, Inc.
  • Helmer Scientific

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Cell Cryopreservation Market is estimated to be valued at USD 12.44 Bn in 2025 and is expected to reach USD 53.64 Bn by 2032, growing at a compound annual growth rate (CAGR) of 23.2% from 2025 to 2032.

Figure. Cell Cryopreservation Market Share (%), By Region 2025

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation-

• By Product Type
  • Cryoprotectant Agents
  • Glycerol
  • Dimethyl Sulfoxide (DMSO)
  • Others
  • Equipment
  • Incubators
  • Liquid Nitrogen Supply Tanks
  • Freezers
  • Others
• By Application
  • Stem Cells
  • Oocytes and Embryotic cells
  • Sperm Cells
  • Hepatocytes
  • Others
• By End User
  • Biopharmaceutical & Pharmaceutical Companies
  • Research Institutes
  • Biobanks
  • IVF clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza Group Ltd.
  • STEMCELL Technologies Inc.
  • BioLife Solutions, Inc.
  • Cryolife, Inc.
  • Organ Recovery Systems Inc.
  • Custom Biogenic Systems
  • Sartorius AG
  • Takara Bio Inc.
  • Chart Industries, Inc.
  • Biocision, LLC
  • Cardinal Health, Inc.
  • Helmer Scientific

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cell Cryopreservation Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cell Cryopreservation Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cryoprotectant Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Glycerol
• Dimethyl Sulfoxide (DMSO)
• Others
• Equipment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Incubators
• Liquid Nitrogen Supply Tanks
• Freezers
• Others

6. Global Cell Cryopreservation Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oocytes and Embryotic cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sperm Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hepatocytes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Cryopreservation Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical & Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biobanks
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• IVF clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Cryopreservation Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lonza Group Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies Inc.
  • BioLife Solutions, Inc.
  • Cryolife, Inc.
  • Organ Recovery Systems Inc.
  • Custom Biogenic Systems
  • Sartorius AG
  • Takara Bio Inc.
  • Chart Industries, Inc.
  • Biocision, LLC
  • Cardinal Health, Inc.
  • Helmer Scientific

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact